Plain-English translation of NCT06409910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial compares two different ways of delivering radiation therapy to the area where the prostate was removed. One approach gives radiation over 4 weeks with daily treatments, while the other gives radiation over 2–3 weeks with treatments every other day. Both approaches aim to treat prostate cancer that may have been left behind after surgery, and the trial is testing whether the shorter schedule works just as well as the longer one.
After prostate surgery, some men need radiation therapy to reduce the risk of cancer coming back. Doctors want to know if a faster treatment schedule with fewer visits can be just as effective and safe as the traditional longer schedule, which would make treatment easier for patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two radiation treatment schedules. You will receive radiation therapy targeting the area where your prostate was removed (and possibly nearby lymph nodes). Depending on which group you're assigned to, you'll receive either daily treatments over about 4 weeks, or treatments every other day over about 2–3 weeks. Your doctors will monitor you during treatment and afterward to check how well the treatment is working and whether you experience any side effects.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Canada